CD8A and melanoma: Although percentages of CD8+ TNaive cells tended to be somewhat lower in young melanoma patients versus young healthy controls, we observed no clear differences between CD8+ T-cell differentiation subsets of melanoma patients and healthy controls (Supplemental Figs. 2a, 2b, 2c and 2d).